SIMILAR PATTERNS OF AMINO ACIDS FOR 4QGI_A_ROCA101

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1azz COLLAGENASE

(Leptuca
pugilator)
PF00089
(Trypsin)
5 GLY A  61
ALA A  61
ASP A  60
THR A  89
THR A  54
None
0.84A 4qgiA-1azzA:
undetectable
4qgiA-1azzA:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cp2 NITROGENASE IRON
PROTEIN


(Clostridium
pasteurianum)
PF00142
(Fer4_NifH)
5 ASP A  38
ALA A  41
GLY A  13
ILE A  12
THR A  18
None
0.98A 4qgiA-1cp2A:
undetectable
4qgiA-1cp2A:
17.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
VAL A  82
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.6A)
None
A79  A 800 (-4.5A)
0.97A 4qgiA-1hvcA:
14.1
4qgiA-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
VAL A  82
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-4.1A)
None
A79  A 800 (-4.5A)
0.92A 4qgiA-1hvcA:
14.1
4qgiA-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
VAL A  82
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
None
A79  A 800 (-4.5A)
0.50A 4qgiA-1hvcA:
14.1
4qgiA-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
VAL A  82
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
None
A79  A 800 (-4.5A)
0.40A 4qgiA-1hvcA:
14.1
4qgiA-1hvcA:
97.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kpl PUTATIVE CLC FAMILY,
CHLORINE TRANSPORT
PROTEIN


(Salmonella
enterica)
PF00654
(Voltage_CLC)
6 GLY A 105
ALA A 104
ILE A 154
THR A 151
ILE A 109
VAL A 122
None
1.29A 4qgiA-1kplA:
undetectable
4qgiA-1kplA:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p2f RESPONSE REGULATOR

(Thermotoga
maritima)
PF00072
(Response_reg)
PF00486
(Trans_reg_C)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  61
THR A  78
None
0.83A 4qgiA-1p2fA:
undetectable
4qgiA-1p2fA:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1poi GLUTACONATE COENZYME
A-TRANSFERASE


(Acidaminococcus
fermentans)
PF01144
(CoA_trans)
5 GLY B 134
GLY B 107
ILE B 106
THR B  31
VAL B  69
None
0.90A 4qgiA-1poiB:
undetectable
4qgiA-1poiB:
18.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
None
0.67A 4qgiA-1q9pA:
10.2
4qgiA-1q9pA:
92.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r76 PECTATE LYASE

(Niveispirillum
irakense)
PF09492
(Pec_lyase)
5 GLY A 252
ALA A 251
THR A 265
ILE A 263
THR A 271
None
0.97A 4qgiA-1r76A:
undetectable
4qgiA-1r76A:
14.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s1d APYRASE

(Homo sapiens)
PF06079
(Apyrase)
5 GLY A 157
ALA A 144
ASP A 112
ILE A 101
VAL A 129
None
None
GP2  A4001 (-4.2A)
TRS  A5001 ( 4.9A)
None
0.94A 4qgiA-1s1dA:
undetectable
4qgiA-1s1dA:
17.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
None
0.45A 4qgiA-1sivA:
18.1
4qgiA-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vrg PROPIONYL-COA
CARBOXYLASE, BETA
SUBUNIT


(Thermotoga
maritima)
PF01039
(Carboxyl_trans)
5 GLY A 416
ALA A 417
ASP A 418
ILE A 346
VAL A 360
None
0.92A 4qgiA-1vrgA:
undetectable
4qgiA-1vrgA:
11.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x0u HYPOTHETICAL
METHYLMALONYL-COA
DECARBOXYLASE ALPHA
SUBUNIT


(Sulfurisphaera
tokodaii)
PF01039
(Carboxyl_trans)
5 GLY A 424
ALA A 425
ASP A 426
ILE A 354
VAL A 368
None
0.91A 4qgiA-1x0uA:
undetectable
4qgiA-1x0uA:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xa0 PUTATIVE NADPH
DEPENDENT
OXIDOREDUCTASES


(Geobacillus
stearothermophilus)
PF00107
(ADH_zinc_N)
5 GLY A 131
ALA A 130
ILE A  66
ILE A  87
VAL A 324
None
SO4  A 329 ( 4.2A)
None
None
None
0.94A 4qgiA-1xa0A:
undetectable
4qgiA-1xa0A:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xfg GLUCOSAMINE--FRUCTOS
E-6-PHOSPHATE
AMINOTRANSFERASE
[ISOMERIZING]


(Escherichia
coli)
PF13522
(GATase_6)
5 ALA A  13
ASP A  11
THR A  67
GLY A  68
ILE A  69
None
0.99A 4qgiA-1xfgA:
undetectable
4qgiA-1xfgA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ywf PHOSPHOTYROSINE
PROTEIN PHOSPHATASE
PTPB


(Mycobacterium
tuberculosis)
PF13350
(Y_phosphatase3)
6 GLY A 261
ALA A 260
ASP A 259
ILE A 246
GLY A 254
VAL A 174
None
1.20A 4qgiA-1ywfA:
undetectable
4qgiA-1ywfA:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)


(Severe acute
respiratory
syndrome-related
coronavirus)
PF01661
(Macro)
5 GLY A 104
ALA A 103
ILE A 132
GLY A 134
VAL A  97
None
0.99A 4qgiA-2favA:
undetectable
4qgiA-2favA:
21.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
0.53A 4qgiA-2fmbA:
14.7
4qgiA-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g40 CONSERVED
HYPOTHETICAL PROTEIN


(Deinococcus
radiodurans)
PF02589
(LUD_dom)
5 GLY A  56
ALA A  57
ILE A 130
THR A 129
GLY A 128
None
0.74A 4qgiA-2g40A:
undetectable
4qgiA-2g40A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4g HYPOTHETICAL PROTEIN

(Corynebacterium
diphtheriae)
PF01872
(RibD_C)
5 GLY A 251
ASP A  61
ILE A  40
THR A  41
ILE A  43
None
EDO  A 278 (-3.2A)
EDO  A 278 ( 3.9A)
None
None
0.95A 4qgiA-2p4gA:
undetectable
4qgiA-2p4gA:
17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r9h H(+)/CL(-) EXCHANGE
TRANSPORTER CLCA


(Escherichia
coli)
PF00654
(Voltage_CLC)
6 GLY A 105
ALA A 104
ILE A 154
THR A 151
GLY A 149
ILE A 109
None
None
None
None
CL  A   2 ( 4.2A)
CL  A   2 ( 4.9A)
1.34A 4qgiA-2r9hA:
undetectable
4qgiA-2r9hA:
13.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
None
0.53A 4qgiA-2rkfA:
20.7
4qgiA-2rkfA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uv8 FATTY ACID SYNTHASE
SUBUNIT BETA (FAS1)


(Saccharomyces
cerevisiae)
PF00698
(Acyl_transf_1)
PF01575
(MaoC_dehydratas)
PF08354
(DUF1729)
PF13452
(MaoC_dehydrat_N)
PF16073
(SAT)
5 GLY G 621
ALA G 620
ILE G 617
GLY G 648
ILE G 676
None
FMN  G3051 ( 4.7A)
None
None
None
0.93A 4qgiA-2uv8G:
undetectable
4qgiA-2uv8G:
4.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2va8 SKI2-TYPE HELICASE

(Sulfolobus
solfataricus)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ALA A 233
ASP A 232
GLY A 355
ILE A 354
VAL A 404
None
0.86A 4qgiA-2va8A:
undetectable
4qgiA-2va8A:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vr2 DIHYDROPYRIMIDINASE

(Homo sapiens)
PF01979
(Amidohydro_1)
5 ASP A 354
GLY A 351
ASP A  65
THR A  87
GLY A  86
None
0.99A 4qgiA-2vr2A:
undetectable
4qgiA-2vr2A:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z51 NIFU-LIKE PROTEIN 2,
CHLOROPLAST


(Arabidopsis
thaliana)
PF01106
(NifU)
5 GLY A 103
ALA A 105
ILE A 123
THR A 124
GLY A 125
None
0.84A 4qgiA-2z51A:
undetectable
4qgiA-2z51A:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z55 ARCHAERHODOPSIN-2

(Halobacterium
sp. AUS-2)
PF01036
(Bac_rhodopsin)
5 GLY A 223
ILE A  51
THR A  28
GLY A  27
ILE A  26
None
0.92A 4qgiA-2z55A:
undetectable
4qgiA-2z55A:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.86A 4qgiA-3aqpA:
undetectable
4qgiA-3aqpA:
9.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c8t FUMARATE LYASE

(Chelativorans
sp. BNC1)
PF00206
(Lyase_1)
PF10397
(ADSL_C)
5 GLY A 341
ALA A 343
ASP A  27
GLY A 132
ILE A 129
None
0.99A 4qgiA-3c8tA:
undetectable
4qgiA-3c8tA:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fhx PYRIDOXAL KINASE

(Homo sapiens)
PF08543
(Phos_pyr_kin)
5 GLY A 234
ALA A 235
THR A  82
GLY A  83
VAL A  14
SO4  A 314 (-3.5A)
SO4  A 314 (-3.6A)
None
None
None
0.86A 4qgiA-3fhxA:
undetectable
4qgiA-3fhxA:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fpc NADP-DEPENDENT
ALCOHOL
DEHYDROGENASE


(Entamoeba
histolytica;
Thermoanaerobacter
brockii)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 211
ALA A 212
ASP A 214
GLY A 192
VAL A 240
None
0.82A 4qgiA-3fpcA:
undetectable
4qgiA-3fpcA:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h8y MAJOR CARBOXYSOME
SHELL PROTEIN 1C


(Halothiobacillus
neapolitanus)
PF00936
(BMC)
5 GLY A  55
ALA A  56
THR A   5
GLY A   6
ILE A   7
None
0.91A 4qgiA-3h8yA:
undetectable
4qgiA-3h8yA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hea ARYLESTERASE

(Pseudomonas
fluorescens)
PF00561
(Abhydrolase_1)
5 GLY A 221
ALA A 249
ILE A 217
GLY A 119
VAL A 255
None
0.99A 4qgiA-3heaA:
undetectable
4qgiA-3heaA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iay DNA POLYMERASE DELTA
CATALYTIC SUBUNIT


(Saccharomyces
cerevisiae)
PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1)
5 ASP A 976
GLY A 975
ALA A 971
ILE A 811
GLY A 598
None
0.81A 4qgiA-3iayA:
undetectable
4qgiA-3iayA:
8.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3imf SHORT CHAIN
DEHYDROGENASE


(Bacillus
anthracis)
PF13561
(adh_short_C2)
5 GLY A  18
ALA A  20
THR A   9
GLY A  10
THR A  56
None
0.97A 4qgiA-3imfA:
undetectable
4qgiA-3imfA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jr2 HEXULOSE-6-PHOSPHATE
SYNTHASE SGBH


(Vibrio cholerae)
PF00215
(OMPdecase)
5 GLY A 147
ASP A 152
ILE A 168
THR A 169
GLY A 170
None
None
None
None
SO4  A 502 (-3.5A)
0.73A 4qgiA-3jr2A:
undetectable
4qgiA-3jr2A:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kje CO
DEHYDROGENASE/ACETYL
-COA SYNTHASE
COMPLEX, ACCESSORY
PROTEIN COOC


(Carboxydothermus
hydrogenoformans)
PF01656
(CbiA)
6 ASP A 138
GLY A  36
ASP A  39
GLY A 142
ILE A 143
VAL A 160
None
1.36A 4qgiA-3kjeA:
undetectable
4qgiA-3kjeA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5


(Homo sapiens)
PF01094
(ANF_receptor)
5 GLY A 224
ASP A 195
ILE A 327
GLY A 306
VAL A 274
None
None
None
GLU  A 506 ( 3.7A)
None
0.97A 4qgiA-3lmkA:
undetectable
4qgiA-3lmkA:
11.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
VAL A  82
None
0.93A 4qgiA-3mwsA:
19.7
4qgiA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
THR A  80
VAL A  82
None
0.62A 4qgiA-3mwsA:
19.7
4qgiA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
THR A  80
VAL A  82
None
0.54A 4qgiA-3mwsA:
19.7
4qgiA-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nfb BETA-PEPTIDYL
AMINOPEPTIDASE


(Sphingosinicella
xenopeptidilytica)
PF03576
(Peptidase_S58)
5 GLY A 239
ASP A 241
GLY A 227
ILE A 225
VAL A 354
None
0.97A 4qgiA-3nfbA:
undetectable
4qgiA-3nfbA:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nnn DNA BINDING RESPONSE
REGULATOR D


(Thermotoga
maritima)
PF00072
(Response_reg)
5 GLY A  96
ALA A  97
ASP A  98
ILE A  64
THR A  81
None
None
None
None
BEF  A 402 (-3.2A)
0.88A 4qgiA-3nnnA:
undetectable
4qgiA-3nnnA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nns DNA BINDING RESPONSE
REGULATOR B


(Thermotoga
maritima)
PF00072
(Response_reg)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  61
THR A  78
None
None
None
None
BEF  A 402 (-3.6A)
0.79A 4qgiA-3nnsA:
undetectable
4qgiA-3nnsA:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nvl 2,3-BISPHOSPHOGLYCER
ATE-INDEPENDENT
PHOSPHOGLYCERATE
MUTASE


(Trypanosoma
brucei)
PF01676
(Metalloenzyme)
PF06415
(iPGM_N)
5 GLY A 198
ILE A 269
THR A 268
GLY A 267
ILE A 266
None
0.82A 4qgiA-3nvlA:
undetectable
4qgiA-3nvlA:
11.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.53A 4qgiA-3t3cA:
18.5
4qgiA-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
THR A  80
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
None
0.62A 4qgiA-3t3cA:
18.5
4qgiA-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
None
0.78A 4qgiA-3ttpA:
19.3
4qgiA-3ttpA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u0o SELENIDE, WATER
DIKINASE


(Escherichia
coli)
PF00586
(AIRS)
PF02769
(AIRS_C)
5 GLY A  96
ASP A  91
GLY A 155
ILE A 156
VAL A  44
None
MG  A 401 (-2.6A)
None
None
None
0.97A 4qgiA-3u0oA:
undetectable
4qgiA-3u0oA:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u0o SELENIDE, WATER
DIKINASE


(Escherichia
coli)
PF00586
(AIRS)
PF02769
(AIRS_C)
5 GLY A  96
THR A 154
GLY A 155
ILE A 156
VAL A  44
None
0.99A 4qgiA-3u0oA:
undetectable
4qgiA-3u0oA:
14.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
None
0.63A 4qgiA-3u7sA:
19.6
4qgiA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
VAL A  82
None
0.40A 4qgiA-3uhlA:
15.9
4qgiA-3uhlA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3umm PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
SYNTHASE


(Salmonella
enterica)
PF02769
(AIRS_C)
PF13507
(GATase_5)
5 GLY A 536
ASP A 533
ILE A  84
THR A  83
GLY A  82
None
0.98A 4qgiA-3ummA:
undetectable
4qgiA-3ummA:
6.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3upn PENICILLIN-BINDING
PROTEIN A


(Mycobacterium
tuberculosis)
PF00905
(Transpeptidase)
5 GLY A  58
ALA A  57
ASP A 135
ILE A  55
VAL A  83
None
0.98A 4qgiA-3upnA:
undetectable
4qgiA-3upnA:
12.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zf4 DUTPASE

(Staphylococcus
virus 80alpha)
PF00692
(dUTPase)
6 GLY A  83
ALA A  84
ASP A  81
GLY A  59
ILE A 140
VAL A  49
None
DUP  A 777 (-3.3A)
DUP  A 777 (-3.6A)
None
None
None
1.39A 4qgiA-3zf4A:
undetectable
4qgiA-3zf4A:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c1n IRON-SULFUR CLUSTER
BINDING PROTEIN


(Carboxydothermus
hydrogenoformans)
PF14574
(DUF4445)
5 GLY I 577
ALA I 578
ILE I 345
GLY I 355
ILE I 357
None
0.91A 4qgiA-4c1nI:
undetectable
4qgiA-4c1nI:
13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dbh 2-HYDROXYHEPTA-2,4-D
IENE-1,7-DIOATE
ISOMERASE


(Corynebacterium
glutamicum)
PF01557
(FAA_hydrolase)
PF10370
(DUF2437)
5 GLY A  99
ALA A  56
ILE A 176
ILE A 144
VAL A  63
None
0.93A 4qgiA-4dbhA:
undetectable
4qgiA-4dbhA:
17.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fi4 MANDELATE
RACEMASE/MUCONATE
LACTONIZING PROTEIN


(Caulobacter sp.
K31)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 GLY A  33
ALA A  89
GLY A 292
ILE A 293
VAL A  67
None
0.89A 4qgiA-4fi4A:
undetectable
4qgiA-4fi4A:
11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hh2 TRANSCRIPTIONAL
REGULATOR, PPSR


(Rhodobacter
sphaeroides)
PF13188
(PAS_8)
PF13426
(PAS_9)
6 GLY A 321
ALA A 315
ASP A 316
ILE A 290
THR A 289
GLY A 288
None
1.44A 4qgiA-4hh2A:
undetectable
4qgiA-4hh2A:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hse CHAPERONE PROTEIN
CLPB


(Thermus
thermophilus)
PF00004
(AAA)
5 ASP A 379
ILE A 382
ILE A 526
THR A 337
VAL A 334
ADP  A 602 (-4.2A)
ADP  A 602 (-4.6A)
None
None
None
0.99A 4qgiA-4hseA:
undetectable
4qgiA-4hseA:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ilk STARVATION SENSING
PROTEIN RSPB


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 206
ALA A 207
ASP A 208
ILE A 190
ILE A 176
None
0.88A 4qgiA-4ilkA:
undetectable
4qgiA-4ilkA:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jga 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 2


(Rickettsia
rickettsii)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 276
ALA A 301
ASP A 304
ILE A 273
ILE A 184
None
0.99A 4qgiA-4jgaA:
undetectable
4qgiA-4jgaA:
13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kws D-MANNONATE
DEHYDRATASE


(Chromohalobacter
salexigens)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 GLY A  34
ILE A  88
GLY A 294
ILE A 295
THR A  68
None
0.83A 4qgiA-4kwsA:
undetectable
4qgiA-4kwsA:
11.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
None
0.85A 4qgiA-4njvA:
20.5
4qgiA-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
0.54A 4qgiA-4njvA:
20.5
4qgiA-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
THR A  80
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
None
0.46A 4qgiA-4njvA:
20.5
4qgiA-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p5p THIJ/PFPI FAMILY
PROTEIN


(Francisella
tularensis)
PF01965
(DJ-1_PfpI)
5 ALA A 218
ILE A 131
GLY A 129
ILE A 128
THR A 156
None
0.95A 4qgiA-4p5pA:
undetectable
4qgiA-4p5pA:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE


(Atopobium
parvulum)
PF00905
(Transpeptidase)
5 GLY A 933
ALA A 934
ILE A 887
GLY A 907
ILE A 906
None
0.98A 4qgiA-4ra7A:
undetectable
4qgiA-4ra7A:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
5 ALA A 175
ASP A 176
ASP A 177
GLY A  12
ILE A 118
None
0.85A 4qgiA-4ttpA:
undetectable
4qgiA-4ttpA:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4upi SULFATASE FAMILY
PROTEIN


(Ruegeria
pomeroyi)
PF00884
(Sulfatase)
5 ASP A  13
ILE A 231
GLY A 100
ILE A  99
THR A 203
ZN  A1576 (-2.1A)
None
None
None
None
0.97A 4qgiA-4upiA:
undetectable
4qgiA-4upiA:
10.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y5x DIABODY 310 VL
DOMAIN


(Homo sapiens)
PF07686
(V-set)
5 GLY A 105
ALA A 104
ILE A  51
THR A  58
VAL A  37
None
0.86A 4qgiA-4y5xA:
undetectable
4qgiA-4y5xA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yai C
ALPHA-DEHYDROGENASE


(Sphingobium sp.
SYK-6)
PF00106
(adh_short)
5 GLY A  20
ALA A  22
THR A  11
GLY A  12
THR A  60
None
None
None
NAI  A 500 (-2.8A)
None
0.97A 4qgiA-4yaiA:
undetectable
4qgiA-4yaiA:
15.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.65A 4qgiA-4ydfA:
12.9
4qgiA-4ydfA:
31.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zoy SQT1

(Chaetomium
thermophilum)
PF00400
(WD40)
5 ASP A 293
ILE A 370
THR A 369
GLY A 368
VAL A 305
None
0.67A 4qgiA-4zoyA:
undetectable
4qgiA-4zoyA:
12.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ahk ACETOLACTATE
SYNTHASE II, LARGE
SUBUNIT


(Pseudomonas
protegens)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ILE A  82
THR A  83
GLY A  84
THR A 131
VAL A 162
None
0.82A 4qgiA-5ahkA:
undetectable
4qgiA-5ahkA:
12.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
0.70A 4qgiA-5b18A:
17.9
4qgiA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
None
0.43A 4qgiA-5b18A:
17.9
4qgiA-5b18A:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b5s ACETIC ACID

(Talaromyces
cellulolyticus)
PF13472
(Lipase_GDSL_2)
6 ASP A  93
GLY A  90
ALA A  65
ILE A 110
THR A 109
GLY A 106
None
1.46A 4qgiA-5b5sA:
undetectable
4qgiA-5b5sA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bok FERREDOXIN

(Diaphorobacter
sp. DS2)
PF00355
(Rieske)
5 GLY A  55
GLY A  21
ILE A  20
THR A  41
VAL A  73
None
0.91A 4qgiA-5bokA:
undetectable
4qgiA-5bokA:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eov 16S/23S RRNA
(CYTIDINE-2'-O)-METH
YLTRANSFERASE TLYA


(Mycobacterium
tuberculosis)
PF01728
(FtsJ)
5 ASP A  88
GLY A  90
ALA A  91
ASP A 112
VAL A  99
None
0.95A 4qgiA-5eovA:
undetectable
4qgiA-5eovA:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqq NS3 PROTEASE

(Hepacivirus C)
PF02907
(Peptidase_S29)
5 GLY A1050
ALA A1087
ILE A1064
GLY A1084
VAL A1033
None
0.98A 4qgiA-5eqqA:
undetectable
4qgiA-5eqqA:
18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h5v FLAGELLAR
HOOK-ASSOCIATED
PROTEIN 2


(Escherichia
coli)
PF02465
(FliD_N)
PF07195
(FliD_C)
5 ALA A 274
ASP A 277
THR A  59
THR A 387
VAL A 378
None
0.94A 4qgiA-5h5vA:
undetectable
4qgiA-5h5vA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ikg DYE-DECOLORIZING
PEROXIDASE


(Auricularia
auricula-judae)
PF04261
(Dyp_perox)
5 GLY A 326
ALA A 325
THR A 308
ILE A 330
THR A 376
None
None
HEM  A 501 (-3.5A)
None
None
0.96A 4qgiA-5ikgA:
undetectable
4qgiA-5ikgA:
12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ikl GERANYL-COA
CARBOXYLASE,
BETA-SUBUNIT


(Pseudomonas
aeruginosa)
PF01039
(Carboxyl_trans)
6 GLY B 190
ILE B 119
THR B 118
GLY B 148
THR B 145
VAL B 183
None
1.44A 4qgiA-5iklB:
undetectable
4qgiA-5iklB:
11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ikl GERANYL-COA
CARBOXYLASE,
BETA-SUBUNIT


(Pseudomonas
aeruginosa)
PF01039
(Carboxyl_trans)
6 GLY B 190
ILE B 119
THR B 118
GLY B 149
THR B 145
VAL B 183
None
1.44A 4qgiA-5iklB:
undetectable
4qgiA-5iklB:
11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j44 SERINE PROTEASE SEPA
AUTOTRANSPORTER


(Shigella
flexneri)
PF02395
(Peptidase_S6)
5 GLY A 172
ALA A  16
ILE A  55
THR A  54
GLY A  63
None
0.90A 4qgiA-5j44A:
undetectable
4qgiA-5j44A:
6.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ovk 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Mycolicibacterium
smegmatis)
no annotation 5 GLY A 123
ALA A 124
ILE A 146
GLY A  98
ILE A  99
None
None
None
NDP  A 301 (-4.5A)
NDP  A 301 ( 4.9A)
0.86A 4qgiA-5ovkA:
undetectable
4qgiA-5ovkA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ovl 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Mycolicibacterium
smegmatis)
no annotation 5 GLY A 123
ALA A 124
ILE A 146
GLY A  98
ILE A  99
None
None
NAP  A1001 (-4.6A)
NAP  A1001 (-3.4A)
NAP  A1001 (-4.5A)
0.84A 4qgiA-5ovlA:
undetectable
4qgiA-5ovlA:
19.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
None
0.67A 4qgiA-5t2zA:
20.0
4qgiA-5t2zA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vpr CYSTEINE DESULFURASE

(Elizabethkingia
anophelis)
PF00266
(Aminotran_5)
6 ASP A 199
GLY A 200
ALA A 201
THR A 232
GLY A 233
ILE A 234
LLP  A 225 ( 2.7A)
None
LLP  A 225 ( 3.6A)
None
None
None
1.34A 4qgiA-5vprA:
undetectable
4qgiA-5vprA:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wug BETA-GLUCOSIDASE

(Paenibacillus
barengoltzii)
no annotation 5 ALA A  43
ILE A 235
GLY A 232
ILE A 588
THR A 584
None
0.87A 4qgiA-5wugA:
undetectable
4qgiA-5wugA:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ykd D-HYDANTOINASE/DIHYD
ROPYRIMIDINASE


(Pseudomonas
aeruginosa)
no annotation 5 ASP A 344
GLY A 341
ASP A  57
THR A  79
GLY A  78
None
0.99A 4qgiA-5ykdA:
undetectable
4qgiA-5ykdA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bhq IGH PROTEIN

(Mus musculus)
no annotation 5 GLY A 431
ILE A 369
THR A 370
GLY A 371
THR A 396
None
0.97A 4qgiA-6bhqA:
undetectable
4qgiA-6bhqA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bvg PROTEIN-N(PI)-PHOSPH
OHISTIDINE-SUGAR
PHOSPHOTRANSFERASE
(ENZYME II OF THE
PHOSPHOTRANSFERASE
SYSTEM) (PTS SYSTEM
GLUCOSE-SPECIFIC
IIBC COMPONENT)


(Bacillus cereus)
no annotation 5 GLY A 153
ALA A  87
ILE A  66
GLY A 146
ILE A 147
None
0.93A 4qgiA-6bvgA:
undetectable
4qgiA-6bvgA:
27.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fay ODZ3 PROTEIN

(Mus musculus)
no annotation 5 ASP A1505
ILE A1445
GLY A1459
ILE A1460
THR A1437
None
0.97A 4qgiA-6fayA:
undetectable
4qgiA-6fayA:
20.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
VAL A  99
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.52A 4qgiA-6fivA:
15.2
4qgiA-6fivA:
30.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
0.82A 4qgiA-6upjA:
17.8
4qgiA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
1.01A 4qgiA-6upjA:
17.8
4qgiA-6upjA:
47.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a6d THERMOSOME (BETA
SUBUNIT)


(Thermoplasma
acidophilum)
PF00118
(Cpn60_TCP1)
5 LEU B 449
ALA B 413
ILE B 503
GLY B 499
ILE B 445
None
0.94A 4qgiB-1a6dB:
undetectable
4qgiB-1a6dB:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1eif EUKARYOTIC
TRANSLATION
INITIATION FACTOR 5A


(Methanocaldococcus
jannaschii)
PF01287
(eIF-5a)
PF08207
(EFP_N)
5 LEU A  15
VAL A  31
GLY A  52
VAL A  48
ILE A  30
None
0.91A 4qgiB-1eifA:
undetectable
4qgiB-1eifA:
21.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.69A 4qgiB-1hvcA:
14.0
4qgiB-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.61A 4qgiB-1hvcA:
14.0
4qgiB-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.62A 4qgiB-1hvcA:
14.0
4qgiB-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ALA A  28
VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.84A 4qgiB-1hvcA:
14.0
4qgiB-1hvcA:
97.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.69A 4qgiB-1hvcA:
14.0
4qgiB-1hvcA:
97.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hyl HYPODERMA LINEATUM
COLLAGENASE


(Hypoderma
lineatum)
PF00089
(Trypsin)
5 LEU A 209
ALA A 136
GLY A 183
VAL A 231
ILE A 210
None
0.87A 4qgiB-1hylA:
undetectable
4qgiB-1hylA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jqe HISTAMINE
N-METHYLTRANSFERASE


(Homo sapiens)
PF13489
(Methyltransf_23)
5 LEU A  71
ASP A  67
ILE A 171
ILE A  59
ILE A  70
None
0.96A 4qgiB-1jqeA:
undetectable
4qgiB-1jqeA:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mro METHYL-COENZYME M
REDUCTASE


(Methanothermobacter
marburgensis)
PF02249
(MCR_alpha)
PF02745
(MCR_alpha_N)
6 LEU A 120
VAL A 124
ILE A 129
ILE A 231
VAL A 115
ILE A 116
None
1.44A 4qgiB-1mroA:
undetectable
4qgiB-1mroA:
10.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
None
0.55A 4qgiB-1q9pA:
10.3
4qgiB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.81A 4qgiB-1sivA:
17.9
4qgiB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.65A 4qgiB-1sivA:
17.9
4qgiB-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2x ADP-SPECIFIC
PHOSPHOFRUCTOKINASE


(Pyrococcus
horikoshii)
PF04587
(ADP_PFK_GK)
5 VAL A 356
GLY A 341
ILE A 344
VAL A 306
ILE A 308
None
0.98A 4qgiB-1u2xA:
undetectable
4qgiB-1u2xA:
11.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u6z EXOPOLYPHOSPHATASE

(Escherichia
coli)
PF02541
(Ppx-GppA)
5 LEU A 285
ALA A 213
ILE A 236
ILE A 220
ILE A 287
None
SO4  A 704 ( 4.5A)
None
None
SO4  A 704 (-4.1A)
0.91A 4qgiB-1u6zA:
undetectable
4qgiB-1u6zA:
12.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usy ATP
PHOSPHORIBOSYLTRANSF
ERASE REGULATORY
SUBUNIT


(Thermotoga
maritima)
PF13393
(tRNA-synt_His)
5 ALA C 251
VAL C 114
ILE C 238
VAL C 109
ILE C 113
None
0.85A 4qgiB-1usyC:
undetectable
4qgiB-1usyC:
14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.88A 4qgiB-1v5fA:
undetectable
4qgiB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.89A 4qgiB-1wsvA:
undetectable
4qgiB-1wsvA:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xbz 3-KETO-L-GULONATE
6-PHOSPHATE
DECARBOXYLASE


(Escherichia
coli)
PF00215
(OMPdecase)
6 ARG A  23
LEU A  24
ALA A 204
VAL A  29
GLY A 191
ILE A  25
None
None
None
None
LX1  A 501 (-3.5A)
None
1.50A 4qgiB-1xbzA:
undetectable
4qgiB-1xbzA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xfj CONSERVED
HYPOTHETICAL PROTEIN


(Caulobacter
vibrioides)
PF02578
(Cu-oxidase_4)
5 ALA A 128
VAL A 146
ILE A 159
GLY A 161
VAL A 141
None
0.85A 4qgiB-1xfjA:
undetectable
4qgiB-1xfjA:
15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yxy PUTATIVE
N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE


(Streptococcus
pyogenes)
PF04131
(NanE)
5 LEU A 182
GLY A 153
ILE A 124
VAL A 189
ILE A 187
None
0.85A 4qgiB-1yxyA:
undetectable
4qgiB-1yxyA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bws XAA-PRO
AMINOPEPTIDASE P


(Escherichia
coli)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 LEU A 433
ILE A 403
ILE A 259
VAL A 424
ILE A 430
None
0.93A 4qgiB-2bwsA:
undetectable
4qgiB-2bwsA:
13.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.64A 4qgiB-2fmbA:
15.0
4qgiB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.69A 4qgiB-2fmbA:
15.0
4qgiB-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hxr HTH-TYPE
TRANSCRIPTIONAL
REGULATOR CYNR


(Escherichia
coli)
PF03466
(LysR_substrate)
5 LEU A 267
VAL A  97
GLY A 107
VAL A 143
ILE A 145
None
0.94A 4qgiB-2hxrA:
undetectable
4qgiB-2hxrA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nr7 SECRETION ACTIVATOR
PROTEIN, PUTATIVE


(Porphyromonas
gingivalis)
PF05838
(Glyco_hydro_108)
PF09374
(PG_binding_3)
5 LEU A 134
GLY A 102
ILE A 103
VAL A  87
ILE A 138
None
0.80A 4qgiB-2nr7A:
undetectable
4qgiB-2nr7A:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ph3 3-OXOACYL-[ACYL
CARRIER PROTEIN]
REDUCTASE


(Thermus
thermophilus)
PF13561
(adh_short_C2)
5 LEU A  28
ALA A   9
VAL A  56
VAL A  54
ILE A  30
None
0.95A 4qgiB-2ph3A:
undetectable
4qgiB-2ph3A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyx TRYPTOPHAN
HALOGENASE


(Shewanella
frigidimarina)
PF04820
(Trp_halogenase)
5 LEU A  42
VAL A 190
GLY A  18
ILE A 349
ILE A  44
None
0.87A 4qgiB-2pyxA:
undetectable
4qgiB-2pyxA:
10.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.84A 4qgiB-2q0lA:
undetectable
4qgiB-2q0lA:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qdl CHEMOTAXIS SIGNAL
TRANSDUCTION PROTEIN


(Caldanaerobacter
subterraneus)
PF01584
(CheW)
5 LEU A  95
VAL A  34
ILE A  14
VAL A  86
ILE A  84
None
GOL  A 166 ( 4.5A)
None
None
None
0.84A 4qgiB-2qdlA:
undetectable
4qgiB-2qdlA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qpz NAPHTHALENE
1,2-DIOXYGENASE
SYSTEM FERREDOXIN
SUBUNIT


(Pseudomonas
putida)
PF00355
(Rieske)
5 LEU A 102
ALA A   7
VAL A  91
ILE A  37
ILE A 100
None
0.94A 4qgiB-2qpzA:
undetectable
4qgiB-2qpzA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r9z GLUTATHIONE AMIDE
REDUCTASE


(Marichromatium
gracile)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 LEU A 105
ALA A  20
ILE A  33
GLY A  12
ILE A 107
None
None
FAD  A 500 ( 4.7A)
FAD  A 500 ( 4.9A)
None
0.95A 4qgiB-2r9zA:
undetectable
4qgiB-2r9zA:
10.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.51A 4qgiB-2rkfA:
19.9
4qgiB-2rkfA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.66A 4qgiB-2rkfA:
19.9
4qgiB-2rkfA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xfl DYNE7

(Micromonospora
chersina)
PF13279
(4HBT_2)
5 ARG A 139
LEU A  90
VAL A 119
VAL A 134
ILE A  95
None
0.95A 4qgiB-2xflA:
undetectable
4qgiB-2xflA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xwu IMPORTIN13

(Homo sapiens)
PF03810
(IBN_N)
PF08389
(Xpo1)
5 LEU B 610
ILE B 640
GLY B 642
VAL B 680
ILE B 614
None
0.85A 4qgiB-2xwuB:
undetectable
4qgiB-2xwuB:
8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z5x AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 600 (-3.2A)
FAD  A 600 (-4.9A)
0.80A 4qgiB-2z5xA:
undetectable
4qgiB-2z5xA:
12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zj8 PUTATIVE SKI2-TYPE
HELICASE


(Pyrococcus
furiosus)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF14520
(HHH_5)
5 LEU A 681
ALA A 661
GLY A 655
VAL A 692
ILE A 687
None
0.90A 4qgiB-2zj8A:
undetectable
4qgiB-2zj8A:
8.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zz8 LIPL32 PROTEIN

(Leptospira
interrogans)
PF12103
(Lipl32)
5 LEU A  63
VAL A 118
ILE A 165
GLY A  75
ILE A 193
None
0.95A 4qgiB-2zz8A:
undetectable
4qgiB-2zz8A:
17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cp8 TRNA URIDINE
5-CARBOXYMETHYLAMINO
METHYL MODIFICATION
ENZYME GIDA


(Chlorobaculum
tepidum)
PF01134
(GIDA)
PF13932
(GIDA_assoc)
5 LEU A 116
ASP A 118
VAL A   7
GLY A 122
ILE A  30
None
0.89A 4qgiB-3cp8A:
undetectable
4qgiB-3cp8A:
10.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dfi PSEUDOAGLYCONE
DEACETYLASE DBV21


(Actinoplanes
teichomyceticus)
PF02585
(PIG-L)
5 LEU A 148
ALA A  12
VAL A  38
GLY A  25
ILE A  10
None
0.83A 4qgiB-3dfiA:
undetectable
4qgiB-3dfiA:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f3k UNCHARACTERIZED
PROTEIN YKR043C


(Saccharomyces
cerevisiae)
PF00300
(His_Phos_1)
5 ARG A 181
VAL A 173
ILE A 155
ILE A 186
ILE A  10
None
0.90A 4qgiB-3f3kA:
undetectable
4qgiB-3f3kA:
16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ht4 ALUMINUM RESISTANCE
PROTEIN


(Bacillus cereus)
PF06838
(Met_gamma_lyase)
5 LEU A 121
GLY A 102
ILE A 103
VAL A 125
ILE A 124
None
0.91A 4qgiB-3ht4A:
undetectable
4qgiB-3ht4A:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jzl PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
monocytogenes)
PF06838
(Met_gamma_lyase)
5 LEU A 114
GLY A  95
ILE A  96
VAL A 118
ILE A 117
None
0.93A 4qgiB-3jzlA:
undetectable
4qgiB-3jzlA:
13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k53 FERROUS IRON
TRANSPORT PROTEIN B


(Pyrococcus
furiosus)
PF02421
(FeoB_N)
6 ALA A   7
ILE A  88
GLY A  10
ILE A  60
VAL A 109
ILE A  85
None
1.20A 4qgiB-3k53A:
undetectable
4qgiB-3k53A:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lkb PROBABLE
BRANCHED-CHAIN AMINO
ACID ABC
TRANSPORTER, AMINO
ACID BINDING PROTEIN


(Thermus
thermophilus)
PF13458
(Peripla_BP_6)
5 ALA A 167
VAL A 146
ILE A 137
VAL A 177
ILE A 174
None
0.75A 4qgiB-3lkbA:
undetectable
4qgiB-3lkbA:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lov PROTOPORPHYRINOGEN
OXIDASE


(Exiguobacterium
sibiricum)
PF01593
(Amino_oxidase)
5 LEU A 387
VAL A 358
ILE A  54
ILE A 402
PRO A 397
None
0.97A 4qgiB-3lovA:
undetectable
4qgiB-3lovA:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgl SULFATE PERMEASE
FAMILY PROTEIN


(Vibrio cholerae)
PF01740
(STAS)
5 LEU A 475
VAL A 532
GLY A 522
VAL A 505
ILE A 507
None
0.97A 4qgiB-3mglA:
undetectable
4qgiB-3mglA:
23.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.67A 4qgiB-3mwsA:
19.3
4qgiB-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
None
0.63A 4qgiB-3mwsA:
19.3
4qgiB-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
VAL A  82
ILE A  84
None
0.72A 4qgiB-3mwsA:
19.3
4qgiB-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nwg MICROCOMPARTMENTS
PROTEIN


(Desulfitobacterium
hafniense)
PF00936
(BMC)
5 LEU A  30
VAL A  52
ILE A  72
ILE A 104
ILE A  45
None
0.98A 4qgiB-3nwgA:
undetectable
4qgiB-3nwgA:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qkc GERANYL DIPHOSPHATE
SYNTHASE SMALL
SUBUNIT


(Antirrhinum
majus)
no annotation 5 LEU B 183
VAL B 154
ILE B 115
VAL B 147
ILE B 153
None
0.85A 4qgiB-3qkcB:
undetectable
4qgiB-3qkcB:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qtg PYRUVATE KINASE

(Pyrobaculum
aerophilum)
PF00224
(PK)
PF02887
(PK_C)
6 LEU A  23
ALA A  52
VAL A  79
ILE A 190
VAL A  45
ILE A  47
None
1.40A 4qgiB-3qtgA:
undetectable
4qgiB-3qtgA:
11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r9u THIOREDOXIN
REDUCTASE


(Campylobacter
jejuni)
PF07992
(Pyr_redox_2)
5 LEU A  14
VAL A 290
ILE A  46
GLY A  58
ILE A  59
None
FAD  A 501 (-4.0A)
FAD  A 501 (-4.3A)
None
None
0.93A 4qgiB-3r9uA:
undetectable
4qgiB-3r9uA:
14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
ALA A  35
VAL A  39
GLY A  56
PRO A  89
None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
3TL  A 126 (-4.0A)
0.67A 4qgiB-3slzA:
11.2
4qgiB-3slzA:
26.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.36A 4qgiB-3t3cA:
18.4
4qgiB-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
None
0.68A 4qgiB-3t3cA:
18.4
4qgiB-3t3cA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqv NICOTINATE-NUCLEOTID
E PYROPHOSPHORYLASE


(Francisella
tularensis)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
5 LEU A 138
VAL A 247
ILE A 232
VAL A 269
ILE A 267
None
0.94A 4qgiB-3tqvA:
undetectable
4qgiB-3tqvA:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsn 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Campylobacter
jejuni)
PF04166
(PdxA)
5 ALA A  44
ILE A   8
GLY A  15
ILE A  14
ILE A  96
None
0.88A 4qgiB-3tsnA:
undetectable
4qgiB-3tsnA:
12.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.74A 4qgiB-3ttpA:
19.1
4qgiB-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.60A 4qgiB-3u7sA:
19.1
4qgiB-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
PRO A  81
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
0.63A 4qgiB-3u7sA:
19.1
4qgiB-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  82
None
0.54A 4qgiB-3uhlA:
16.0
4qgiB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
None
0.55A 4qgiB-3uhlA:
16.0
4qgiB-3uhlA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v10 RHUSIOPATHIAE
SURFACE PROTEIN B


(Erysipelothrix
rhusiopathiae)
PF05737
(Collagen_bind)
5 ALA A 261
VAL A 246
ILE A 269
GLY A 267
ILE A 257
None
0.85A 4qgiB-3v10A:
undetectable
4qgiB-3v10A:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v70 GTPASE IMAP FAMILY
MEMBER 1


(Homo sapiens)
PF04548
(AIG1)
5 LEU A 115
VAL A  81
GLY A 102
VAL A  33
ILE A  31
None
0.81A 4qgiB-3v70A:
undetectable
4qgiB-3v70A:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.92A 4qgiB-3vidA:
undetectable
4qgiB-3vidA:
15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wrc GALLATE DIOXYGENASE

(Sphingomonas
paucimobilis)
PF02900
(LigB)
PF07746
(LigA)
5 LEU A  99
ALA A 172
GLY A 166
VAL A 145
ILE A 103
None
0.89A 4qgiB-3wrcA:
undetectable
4qgiB-3wrcA:
13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wxm PROTEIN PELOTA
HOMOLOG


(Aeropyrum
pernix)
PF03463
(eRF1_1)
PF03465
(eRF1_3)
5 ALA B 129
VAL B 195
ILE B 244
VAL B 232
ILE B 131
None
0.96A 4qgiB-3wxmB:
undetectable
4qgiB-3wxmB:
13.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.79A 4qgiB-3wzdA:
undetectable
4qgiB-3wzdA:
15.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
487d PROTEIN (50S L2
RIBOSOMAL PROTEIN)


(Geobacillus
stearothermophilus)
PF00181
(Ribosomal_L2)
PF03947
(Ribosomal_L2_C)
5 LEU I 153
ALA I 161
ILE I 134
ILE I 172
ILE I 143
None
0.94A 4qgiB-487dI:
undetectable
4qgiB-487dI:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a1o BIFUNCTIONAL PURINE
BIOSYNTHESIS PROTEIN
PURH


(Mycobacterium
tuberculosis)
PF01808
(AICARFT_IMPCHas)
PF02142
(MGS)
5 LEU A 352
GLY A 315
ILE A 281
VAL A 360
ILE A 358
None
0.89A 4qgiB-4a1oA:
undetectable
4qgiB-4a1oA:
10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a2l TWO-COMPONENT SYSTEM
SENSOR HISTIDINE
KINASE/RESPONSE


(Bacteroides
thetaiotaomicron)
PF07494
(Reg_prop)
PF07495
(Y_Y_Y)
5 ARG A 505
VAL A 558
GLY A 515
ILE A 500
ILE A 548
None
0.96A 4qgiB-4a2lA:
undetectable
4qgiB-4a2lA:
8.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a4l SERINE/THREONINE-PRO
TEIN KINASE PLK1


(Homo sapiens)
PF00069
(Pkinase)
5 LEU A 182
VAL A 113
ILE A 296
VAL A 190
ILE A 192
None
0.97A 4qgiB-4a4lA:
undetectable
4qgiB-4a4lA:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.90A 4qgiB-4agdA:
undetectable
4qgiB-4agdA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ao7 ESTERASE

(unidentified)
PF12146
(Hydrolase_4)
5 ALA A 125
VAL A  31
ILE A 119
PRO A  82
ILE A  79
None
0.93A 4qgiB-4ao7A:
undetectable
4qgiB-4ao7A:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c30 DNA HELICASE II

(Deinococcus
radiodurans)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 ALA A 180
GLY A 130
ILE A 135
VAL A 143
ILE A 144
None
0.95A 4qgiB-4c30A:
undetectable
4qgiB-4c30A:
10.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4clc UPF0303 PROTEIN
YBR137W


(Saccharomyces
cerevisiae)
PF03928
(Haem_degrading)
6 LEU E 151
ALA E 160
ILE E  63
GLY E  43
VAL E  59
ILE E 148
None
1.35A 4qgiB-4clcE:
undetectable
4qgiB-4clcE:
17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cns DIHYDROPYRIMIDINASE-
LIKE 3


(Homo sapiens)
PF01979
(Amidohydro_1)
5 LEU A 283
ILE A  66
GLY A  69
VAL A 364
ILE A 365
None
0.97A 4qgiB-4cnsA:
undetectable
4qgiB-4cnsA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d1t METALLO-B-LACTAMASE

(Pseudomonas
aeruginosa)
PF00753
(Lactamase_B)
5 LEU A  96
ALA A  86
ILE A  56
GLY A  71
ILE A  83
None
0.88A 4qgiB-4d1tA:
undetectable
4qgiB-4d1tA:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fx5 VON WILLEBRAND
FACTOR TYPE A


(Catenulispora
acidiphila)
PF13768
(VWA_3)
5 ALA A 159
VAL A  96
ILE A 148
GLY A 146
ILE A  59
None
0.90A 4qgiB-4fx5A:
undetectable
4qgiB-4fx5A:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jdu AEROTOLERANCE-RELATE
D MEMBRANE PROTEIN


(Bacteroides
fragilis)
PF00092
(VWA)
5 LEU A 223
ALA A 115
ILE A 160
VAL A 194
ILE A 196
None
MLY  A 116 ( 3.1A)
MLY  A 116 ( 4.2A)
None
None
0.96A 4qgiB-4jduA:
undetectable
4qgiB-4jduA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jq9 DIHYDROLIPOYL
DEHYDROGENASE


(Escherichia
coli)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ALA A 428
VAL A 452
GLY A 410
ILE A 409
ILE A 438
None
0.94A 4qgiB-4jq9A:
undetectable
4qgiB-4jq9A:
11.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
VAL A  32
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-3.6A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.64A 4qgiB-4njvA:
19.6
4qgiB-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
RIT  A 500 (-3.2A)
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
0.45A 4qgiB-4njvA:
19.6
4qgiB-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.73A 4qgiB-4njvA:
19.6
4qgiB-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nky STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE


(Homo sapiens)
PF00067
(p450)
5 LEU A 396
VAL A  76
ILE A 381
ILE A  87
ILE A 394
None
0.93A 4qgiB-4nkyA:
undetectable
4qgiB-4nkyA:
10.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nox EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT B


(Chaetomium
thermophilum)
PF08662
(eIF2A)
6 LEU A 329
ALA A 327
VAL A 351
ILE A 397
VAL A 356
ILE A 335
None
1.28A 4qgiB-4noxA:
undetectable
4qgiB-4noxA:
9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nu2 ANTIFREEZE PROTEIN

(Flavobacterium
frigoris)
PF11999
(DUF3494)
5 LEU A 178
VAL A 229
GLY A 239
ILE A 221
VAL A 198
None
0.96A 4qgiB-4nu2A:
undetectable
4qgiB-4nu2A:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqr CYP105AS1

(Amycolatopsis
orientalis)
PF00067
(p450)
5 LEU A 312
VAL A  50
ILE A  61
VAL A 315
ILE A 310
None
0.94A 4qgiB-4oqrA:
undetectable
4qgiB-4oqrA:
14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqs CYP105AS1

(Amycolatopsis
orientalis)
PF00067
(p450)
5 LEU A 312
VAL A  50
ILE A  61
VAL A 315
ILE A 310
None
0.97A 4qgiB-4oqsA:
undetectable
4qgiB-4oqsA:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p8r GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE,
CYTOSOLIC


(Trypanosoma
brucei)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA A  21
VAL A   5
ILE A 326
ILE A  13
ILE A  29
MG  A 401 (-4.5A)
None
None
NAD  A 400 (-4.3A)
None
0.94A 4qgiB-4p8rA:
undetectable
4qgiB-4p8rA:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pv4 PROLINE
AMINOPEPTIDASE P II


(Yersinia pestis)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 LEU A 432
ILE A 402
ILE A 257
VAL A 423
ILE A 429
None
0.95A 4qgiB-4pv4A:
undetectable
4qgiB-4pv4A:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pyr PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC TRANSPORTER


(Chromobacterium
violaceum)
PF04348
(LppC)
5 LEU A 166
VAL A  88
GLY A 107
ILE A 337
ILE A 146
None
0.84A 4qgiB-4pyrA:
undetectable
4qgiB-4pyrA:
13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tv7 HTH-TYPE
TRANSCRIPTIONAL
REGULATORY PROTEIN
GABR


(Bacillus
subtilis)
PF00155
(Aminotran_1_2)
PF00392
(GntR)
5 ALA A 268
ILE A 234
ILE A 262
PRO A 246
ILE A 276
None
0.93A 4qgiB-4tv7A:
undetectable
4qgiB-4tv7A:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xxp PUTATIVE
UNCHARACTERIZED
PROTEIN (RV0315
ORTHOLOG)


(Mycobacterium
avium)
PF00722
(Glyco_hydro_16)
5 LEU A 152
VAL A 177
GLY A 208
VAL A 162
ILE A 160
None
0.91A 4qgiB-4xxpA:
undetectable
4qgiB-4xxpA:
16.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 ARG A  10
LEU A  30
ASP A  32
ALA A  35
VAL A  39
GLY A  58
ILE A 100
None
None
4B1  A 201 (-2.9A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.67A 4qgiB-4ydfA:
12.9
4qgiB-4ydfA:
31.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
6 VAL A 221
ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
1.09A 4qgiB-4ywlA:
undetectable
4qgiB-4ywlA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a87 METALLO-BETA-LACTAMA
SE VIM-5


(Klebsiella
pneumoniae)
PF00753
(Lactamase_B)
5 LEU A  96
ALA A  86
ILE A  57
GLY A  71
ILE A  83
None
0.90A 4qgiB-5a87A:
undetectable
4qgiB-5a87A:
17.14